taxonomy (1)
protein (1)
source (5)
structure (10)
composition (61)
disease (4)
reference (13)
site (6)
peptide (22)
- Homo sapiens (Human)
Taxonomy
- Blood Plasma (UBERON_0001969)
- Blood Serum (UBERON_0001977)
- Mammary Gland (UBERON_0001911)
- Urine (UBERON_0001088)
- Cerebrospinal Fluid Secretion (GO_0033326)
Source
- N-Linked / Complex / Structure 2011
- N-Linked / Complex / Gal(?1-?)GlcNAc(?1-?)Man(a1-3)[Gal(?1-?)GlcNAc(?1-?)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / Complex / Gal(b1-4)GlcNAc(b1-2)Man(a1-3)[Gal(b1-4)GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / Hybrid / Structure 2063
- N-Linked / Complex / Gal(b1-4)GlcNAc(b1-2)Man(a1-3)[Gal(b1-4)GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Complex / Structure 3041
- N-Linked / Complex / Structure 644
- N-Linked / Complex / NeuAc(?2-?)Gal(?1-?)GlcNAc(?1-?)Man(a1-3)[NeuAc(?2-?)Gal(?1-?)GlcNAc(?1-?)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / Complex / NeuAc(a2-6)Gal(b1-4)GlcNAc(b1-2)Man(a1-3)[NeuAc(a2-6)Gal(b1-4)GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / Complex / NeuAc(a2-3)Gal(b1-4)GlcNAc(b1-4)[NeuAc(a2-6)Gal(b1-4)GlcNAc(b1-2)]Man(a1-?)[NeuAc(a2-6)Gal(b1-4)GlcNAc(b1-2)Man(a1-?)]Man(b1-4)GlcNAc(b1-4)GlcNAc
Reported structure
- Hex:3 HexNAc:2 (avg mass : 910.8325 )
- Hex:3 HexNAc:6 dHex:2 NeuAc:1 (avg mass : 2307.1564 )
- Hex:3 HexNAc:7 (avg mass : 1926.8075 )
- Hex:3 HexNAc:9 dHex:1 (avg mass : 2479.3405 )
- Hex:4 HexNAc:3 NeuAc:1 (avg mass : 1567.4278 )
- Hex:4 HexNAc:4 (avg mass : 1479.3649 )
- Hex:4 HexNAc:4 NeuAc:1 (avg mass : 1770.6228 )
- Hex:4 HexNAc:4 dHex:1 NeuAc:1 (avg mass : 1916.7658 )
- Hex:4 HexNAc:4 dHex:2 NeuAc:1 (avg mass : 2062.9088 )
- Hex:4 HexNAc:5 NeuAc:1 NeuGc:1
- Hex:4 HexNAc:5 dHex:2 NeuAc:1 (avg mass : 2266.1038 )
- Hex:4 HexNAc:5 dHex:3 (avg mass : 2120.9889 )
- Hex:4 HexNAc:6 dHex:1 (avg mass : 2031.8979 )
- Hex:4 HexNAc:6 dHex:2 (avg mass : 2178.0409 )
- Hex:5 HexNAc:3 NeuAc:1 (avg mass : 1729.5702 )
- Hex:5 HexNAc:4 (avg mass : 1641.5073 )
- Hex:5 HexNAc:4 NeuAc:1 (avg mass : 1932.7652 )
- Hex:5 HexNAc:4 NeuAc:2 (avg mass : 2224.0231 )
- Hex:5 HexNAc:4 dHex:1 (avg mass : 1787.6503 )
- Hex:5 HexNAc:4 dHex:1 NeuAc:1 (avg mass : 2078.9082 )
- Hex:5 HexNAc:4 dHex:1 NeuAc:1 NeuGc:1 (avg mass : 2386.1655 )
- Hex:5 HexNAc:4 dHex:1 NeuAc:2 (avg mass : 2370.1661 )
- Hex:5 HexNAc:4 dHex:2 NeuAc:1 (avg mass : 2225.0512 )
- Hex:5 HexNAc:4 dHex:3 (avg mass : 2079.9363 )
- Hex:5 HexNAc:4 dHex:3 NeuAc:1 (avg mass : 2371.1942 )
- Hex:5 HexNAc:5 NeuAc:2 (avg mass : 2427.2181 )
- Hex:5 HexNAc:5 dHex:1 NeuAc:1 (avg mass : 2282.1032 )
- Hex:5 HexNAc:5 dHex:2 (avg mass : 2136.9883 )
- Hex:5 HexNAc:6 dHex:1 (avg mass : 2194.0403 )
- Hex:5 HexNAc:6 dHex:3 (avg mass : 2486.3263 )
- Hex:5 HexNAc:8 (avg mass : 2454.2873 )
- Hex:6 HexNAc:4 NeuAc:1 (avg mass : 2094.9076 )
- Hex:6 HexNAc:4 NeuAc:2 (avg mass : 2386.1655 )
- Hex:6 HexNAc:4 dHex:1 (avg mass : 1949.7927 )
- Hex:6 HexNAc:4 dHex:1 NeuAc:1 (avg mass : 2241.0506 )
- Hex:6 HexNAc:4 dHex:2 NeuAc:1
- Hex:6 HexNAc:4 dHex:3 (avg mass : 2242.0787 )
- Hex:6 HexNAc:5 (avg mass : 2006.8447 )
- Hex:6 HexNAc:5 NeuAc:1 (avg mass : 2298.1026 )
- Hex:6 HexNAc:5 NeuAc:2 (avg mass : 2589.3605 )
- Hex:6 HexNAc:5 NeuAc:3 (avg mass : 2880.6184 )
- Hex:6 HexNAc:5 dHex:1 (avg mass : 2152.9877 )
- Hex:6 HexNAc:5 dHex:1 NeuAc:1 (avg mass : 2444.2456 )
- Hex:6 HexNAc:5 dHex:1 NeuAc:2 (avg mass : 2735.5035 )
- Hex:6 HexNAc:5 dHex:1 NeuAc:3 (avg mass : 3026.7614 )
- Hex:6 HexNAc:5 dHex:2 NeuAc:1 (avg mass : 2590.3886 )
- Hex:6 HexNAc:5 dHex:2 NeuAc:2 (avg mass : 2881.6465 )
- Hex:6 HexNAc:6 (avg mass : 2210.0397 )
- Hex:6 HexNAc:6 NeuAc:2 (avg mass : 2792.5555 )
- Hex:6 HexNAc:6 dHex:1 (avg mass : 2356.1827 )
- Hex:6 HexNAc:6 dHex:1 NeuAc:2 (avg mass : 2938.6985 )
- Hex:6 HexNAc:7 (avg mass : 2413.2347 )
- Hex:7 HexNAc:4 NeuAc:1 (avg mass : 2257.05 )
- Hex:7 HexNAc:4 dHex:1 (avg mass : 2111.9351 )
- Hex:7 HexNAc:5 dHex:1 NeuAc:2 (avg mass : 2897.6459 )
- Hex:7 HexNAc:6 NeuAc:2 (avg mass : 2954.6979 )
- Hex:7 HexNAc:6 dHex:1 NeuAc:2 (avg mass : 3100.8409 )
- Hex:7 HexNAc:6 dHex:1 NeuAc:4 (avg mass : 3683.3567 )
- Hex:7 HexNAc:6 dHex:3 NeuAc:1
- Hex:8 HexNAc:3 dHex:3 NeuAc:1
- Hex:12 HexNAc:2 (avg mass : 2370.1141 )
Composition
- Cancer, breast (DOID:1612)
- Carcinoma, Hepatocellular (DOID:684)
- Esophageal cancer (DOID:5041)
- Prostate cancer (DOID:10283)
Disease
- Reanalysis of global proteomic and phosphoproteomic data identified a large number of glycopeptides (2018 - Yingwei Hu, Punit Shah, David J. Clark, Minghui Ao, Hui Zhang) / Status : Unreviewed
- Distinct urinary glycoprotein signatures in prostate cancer patients (2018 - Rebeca Kawahara, Fabio Ortega, Livia Rosa-Fernandes, Vanessa Guimarães, Daniel Quina, Willian Nahas, Veit Schwämmle, Miguel Srougi, Katia R.M. Leite, Morten Thaysen-Andersen, Martin R. Larsen and Giuseppe Palmisano) / Status : Unreviewed
- Site-Specific Profiling of Serum Glycoproteins Using N-Linked Glycan and Glycosite Analysis Revealing Atypical N-Glycosylation Sites on Albumin and α-1B-Glycoprotein (2018 - Shisheng Sun, Yingwei Hu, Li Jia, Shadi Toghi Eshghi, Yang Liu, Punit Shah, Hui Zhang) / Status : Unreviewed
- Large-scale intact glycopeptide identification by Mascot database search (2018 - Ravi Chand Bollineni, Christian Jeffrey Koehler, Randi Elin Gislefoss, Jan Haug Anonsen, Bernd Thiede) / Status : Unreviewed
- Glycomic analysis of high density lipoprotein shows a highly sialylated particle (2014 - Huang J1, Lee H, Zivkovic AM, Smilowitz JT, Rivera N, German JB, Lebrilla CB) / Status : Reviewed
- Selective glycopeptide profiling by acetone enrichment and LC/MS (2014 - Takakura D, Harazono A, Hashii N, Kawasaki N) / Status : Reviewed
- Comparison of sialylated N-glycopeptide levels in serum of pancreatic cancer patients, acute pancreatitis patients, and healthy controls (2014 - Kontro H, Joenväärä S, Haglund C, Renkonen R) / Status : Reviewed
- Computational framework for identification of intact glycopeptides in complex samples (2014 - Mayampurath A, Yu CY, Song E, Balan J, Mechref Y, Tang H.) / Status : Reviewed
- Human urinary glycoproteomics; attachment site specific analysis of N- and O-linked glycosylations by CID and ECD (2012 - Halim A, Nilsson J, Rüetschi U, Hesse C, Larson G) / Status : Reviewed
- Enrichment of glycopeptides for glycan structure and attachment site identification (2009 - Nilsson J, Rüetschi U, Halim A, Hesse C, Carlsohn E, Brinkmalm G, Larson G.) / Status : Reviewed
- Simultaneous glycosylation analysis of human serum glycoproteins by high-performance liquid chromatography/tandem mass spectrometry (2008 - Harazono A, Kawasaki N, Itoh S, Hashii N, Matsuishi-Nakajima Y, Kawanishi T, Yamaguchi T) / Status : Reviewed
- Structural analysis on the sugar chains of human alpha 1-antitrypsin: presence of fucosylated biantennary glycan in hepatocellular carcinoma. (1993 - Saitoh A, Aoyagi Y, Asakura H) / Status : Reviewed
- Studies on the oligosaccharide chains of human alpha 1-protease inhibitor. II. Structure of oligosaccharides. (1980 - Mega T, Lujan E, Yoshida A) / Status : Reviewed
Reference
- Alpha-1-antitrypsin / Homo sapiens
Reported glycosite
- QLAHQSNSTNIFFSPVSIATAFAMLSLGTK (30aa)
- QLAHQSNSTNIFFSPVSIATAF (22aa)
- QLAHQSNSTNIF (12aa)
- QLAHQSNSTNIFFSPV (16aa)
- QLAHQSNSTNIFF (13aa)
- ADTHDEILEGLNFNLTEIPEAQ (22aa)
- ADTHDEILEGLNFNLTEIPEAQIHEGFQEL (30aa)
- ADTHDEILEGLNFNLTEIPEAQIH (24aa)
- ADTHDEILEGLNFNLTEIPEAQIHEGF (27aa)
- ADTHDEILEGLNFNLTEIPEAQIHE (25aa)
- ADTHDEIIEGINFNITEIPEAQIHEGFQEIIR (32aa)
- ADTHDEILEGLNFNLTEIPEAQIHEG (26aa)
- ADTHDEILEGLNFNLT (16aa)
- NATAIFFLPDEGK (13aa)
- YIGNATAIFFIPDEGKIQHIENEITHDIITK (31aa)
- YLGNATAI (8aa)
- YIGNATAIFFIPDEGK (16aa)
- LGNATAIFFLPDEGK (15aa)
- KYLGNATAIFFLPDEGK (17aa)
- YLGNATAIFFLPDEGK (16aa)
- YLGNATAIFFLPDEGK (16aa)
- YLGNATAIF (9aa)
- VVNPTQK (7aa)
Mass spectrometry observed peptide
-
- N-Linked / Complex (avg mass : 1479.3649)
- Alpha-1-antitrypsin / Homo sapiens
-
- N-Linked / Complex (avg mass : 1641.5073)
- Alpha-1-antitrypsin / Homo sapiens
- Alpha-1-antitrypsin / Homo sapiens
-
- N-Linked / Complex (avg mass : 1641.5073)
- Blood Serum (UBERON_0001977)
- Carcinoma, Hepatocellular (DOID:684)
-
Alpha-1-antitrypsin / Homo sapiens
- Undefined site
- Alpha-1-antitrypsin / Homo sapiens
-
- N-Linked / Hybrid (avg mass : 1729.5702)
- Blood Plasma (UBERON_0001969)
- Esophageal cancer (DOID:5041)
- Alpha-1-antitrypsin / Homo sapiens
-
- N-Linked / Complex (avg mass : 1787.6503)
- Blood Serum (UBERON_0001977)
- Carcinoma, Hepatocellular (DOID:684)
-
Alpha-1-antitrypsin / Homo sapiens
- Undefined site
- Alpha-1-antitrypsin / Homo sapiens
-
- N-Linked / Complex (avg mass : 1787.6503)
- Alpha-1-antitrypsin / Homo sapiens
- Alpha-1-antitrypsin / Homo sapiens
-
- N-Linked / Complex (avg mass : 2006.8447)
- Alpha-1-antitrypsin / Homo sapiens
-
- N-Linked / Complex (avg mass : 2224.0231)
- Blood Plasma (UBERON_0001969)
- Esophageal cancer (DOID:5041)
- Alpha-1-antitrypsin / Homo sapiens
- Alpha-1-antitrypsin / Homo sapiens
-
- N-Linked / Complex (avg mass : 2224.0231)
- Blood Serum (UBERON_0001977)
-
Alpha-1-antitrypsin / Homo sapiens
- Undefined site
- Alpha-1-antitrypsin / Homo sapiens
-
- N-Linked / Complex (avg mass : 2880.6184)
- Blood Serum (UBERON_0001977)
-
Alpha-1-antitrypsin / Homo sapiens
- Undefined site
- Alpha-1-antitrypsin / Homo sapiens
-
- Hex:3 HexNAc:2 / N-Linked (avg mass : 910.8325)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Alpha-1-antitrypsin / Homo sapiens
- YIGNATAIFFIPDEGK (16aa)
-
- Hex:4 HexNAc:3 NeuAc:1 / N-Linked (avg mass : 1567.4278)
- Reanalysis of global proteomic and phosphoproteomic data identified a large number of glycopeptides (2018 - Yingwei Hu, Punit Shah, David J. Clark, Minghui Ao, Hui Zhang) / Status : Unreviewed
- Large-scale intact glycopeptide identification by Mascot database search (2018 - Ravi Chand Bollineni, Christian Jeffrey Koehler, Randi Elin Gislefoss, Jan Haug Anonsen, Bernd Thiede) / Status : Unreviewed
- Alpha-1-antitrypsin / Homo sapiens
- YLGNATAIFFLPDEGK (16aa)
- YLGNATAIFFLPDEGK (16aa)
- YIGNATAIFFIPDEGK (16aa)
-
- Hex:5 HexNAc:4 / N-Linked (avg mass : 1641.5073)
- N-Linked / Complex / Gal(?1-?)GlcNAc(?1-?)Man(a1-3)[Gal(?1-?)GlcNAc(?1-?)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / Complex / Gal(b1-4)GlcNAc(b1-2)Man(a1-3)[Gal(b1-4)GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- Cancer, breast (DOID:1612)
- Site-Specific Profiling of Serum Glycoproteins Using N-Linked Glycan and Glycosite Analysis Revealing Atypical N-Glycosylation Sites on Albumin and α-1B-Glycoprotein (2018 - Shisheng Sun, Yingwei Hu, Li Jia, Shadi Toghi Eshghi, Yang Liu, Punit Shah, Hui Zhang) / Status : Unreviewed
- Reanalysis of global proteomic and phosphoproteomic data identified a large number of glycopeptides (2018 - Yingwei Hu, Punit Shah, David J. Clark, Minghui Ao, Hui Zhang) / Status : Unreviewed
- Human urinary glycoproteomics; attachment site specific analysis of N- and O-linked glycosylations by CID and ECD (2012 - Halim A, Nilsson J, Rüetschi U, Hesse C, Larson G) / Status : Reviewed
- Alpha-1-antitrypsin / Homo sapiens
- YLGNATAIFFLPDEGK (16aa)
- YLGNATAIFFLPDEGK (16aa)
- YIGNATAIFFIPDEGK (16aa)
-
- Hex:4 HexNAc:4 NeuAc:1 / N-Linked (avg mass : 1770.6228)
- Site-Specific Profiling of Serum Glycoproteins Using N-Linked Glycan and Glycosite Analysis Revealing Atypical N-Glycosylation Sites on Albumin and α-1B-Glycoprotein (2018 - Shisheng Sun, Yingwei Hu, Li Jia, Shadi Toghi Eshghi, Yang Liu, Punit Shah, Hui Zhang) / Status : Unreviewed
- Reanalysis of global proteomic and phosphoproteomic data identified a large number of glycopeptides (2018 - Yingwei Hu, Punit Shah, David J. Clark, Minghui Ao, Hui Zhang) / Status : Unreviewed
- Large-scale intact glycopeptide identification by Mascot database search (2018 - Ravi Chand Bollineni, Christian Jeffrey Koehler, Randi Elin Gislefoss, Jan Haug Anonsen, Bernd Thiede) / Status : Unreviewed
- Alpha-1-antitrypsin / Homo sapiens
- YLGNATAIFFLPDEGK (16aa)
- YLGNATAIFFLPDEGK (16aa)
- YIGNATAIFFIPDEGK (16aa)
-
- Hex:5 HexNAc:4 dHex:1 / N-Linked (avg mass : 1787.6503)
- Blood Plasma (UBERON_0001969)
- N-Linked / Complex / Gal(b1-4)GlcNAc(b1-2)Man(a1-3)[Gal(b1-4)GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Complex / Structure 3041
- Alpha-1-antitrypsin / Homo sapiens
-
- Hex:4 HexNAc:4 dHex:1 NeuAc:1 / N-Linked (avg mass : 1916.7658)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Alpha-1-antitrypsin / Homo sapiens
- YIGNATAIFFIPDEGK (16aa)
-
- Hex:3 HexNAc:7 / N-Linked (avg mass : 1926.8075)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Alpha-1-antitrypsin / Homo sapiens
- YIGNATAIFFIPDEGK (16aa)
-
- Hex:5 HexNAc:4 NeuAc:1 / N-Linked (avg mass : 1932.7652)
- Site-Specific Profiling of Serum Glycoproteins Using N-Linked Glycan and Glycosite Analysis Revealing Atypical N-Glycosylation Sites on Albumin and α-1B-Glycoprotein (2018 - Shisheng Sun, Yingwei Hu, Li Jia, Shadi Toghi Eshghi, Yang Liu, Punit Shah, Hui Zhang) / Status : Unreviewed
- Reanalysis of global proteomic and phosphoproteomic data identified a large number of glycopeptides (2018 - Yingwei Hu, Punit Shah, David J. Clark, Minghui Ao, Hui Zhang) / Status : Unreviewed
- Large-scale intact glycopeptide identification by Mascot database search (2018 - Ravi Chand Bollineni, Christian Jeffrey Koehler, Randi Elin Gislefoss, Jan Haug Anonsen, Bernd Thiede) / Status : Unreviewed
- Distinct urinary glycoprotein signatures in prostate cancer patients (2018 - Rebeca Kawahara, Fabio Ortega, Livia Rosa-Fernandes, Vanessa Guimarães, Daniel Quina, Willian Nahas, Veit Schwämmle, Miguel Srougi, Katia R.M. Leite, Morten Thaysen-Andersen, Martin R. Larsen and Giuseppe Palmisano) / Status : Unreviewed
- Alpha-1-antitrypsin / Homo sapiens
- QLAHQSNSTNIFFSPVSIATAFAMLSLGTK (30aa)
- ADTHDEIIEGINFNITEIPEAQIHEGFQEIIR (32aa)
- YLGNATAI (8aa)
- YLGNATAIFFLPDEGK (16aa)
- YLGNATAIFFLPDEGK (16aa)
- YIGNATAIFFIPDEGK (16aa)
-
- Hex:6 HexNAc:4 dHex:1 / N-Linked (avg mass : 1949.7927)
- Reanalysis of global proteomic and phosphoproteomic data identified a large number of glycopeptides (2018 - Yingwei Hu, Punit Shah, David J. Clark, Minghui Ao, Hui Zhang) / Status : Unreviewed
- Distinct urinary glycoprotein signatures in prostate cancer patients (2018 - Rebeca Kawahara, Fabio Ortega, Livia Rosa-Fernandes, Vanessa Guimarães, Daniel Quina, Willian Nahas, Veit Schwämmle, Miguel Srougi, Katia R.M. Leite, Morten Thaysen-Andersen, Martin R. Larsen and Giuseppe Palmisano) / Status : Unreviewed
- Alpha-1-antitrypsin / Homo sapiens
- ADTHDEIIEGINFNITEIPEAQIHEGFQEIIR (32aa)
- YLGNATAIFFLPDEGK (16aa)
- YLGNATAIFFLPDEGK (16aa)
- YIGNATAIFFIPDEGK (16aa)
-
- Hex:4 HexNAc:6 dHex:1 / N-Linked (avg mass : 2031.8979)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Alpha-1-antitrypsin / Homo sapiens
- YIGNATAIFFIPDEGK (16aa)
-
- Hex:4 HexNAc:4 dHex:2 NeuAc:1 / N-Linked (avg mass : 2062.9088)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Alpha-1-antitrypsin / Homo sapiens
- YIGNATAIFFIPDEGK (16aa)
-
- Hex:5 HexNAc:4 dHex:1 NeuAc:1 / N-Linked (avg mass : 2078.9082)
- Site-Specific Profiling of Serum Glycoproteins Using N-Linked Glycan and Glycosite Analysis Revealing Atypical N-Glycosylation Sites on Albumin and α-1B-Glycoprotein (2018 - Shisheng Sun, Yingwei Hu, Li Jia, Shadi Toghi Eshghi, Yang Liu, Punit Shah, Hui Zhang) / Status : Unreviewed
- Reanalysis of global proteomic and phosphoproteomic data identified a large number of glycopeptides (2018 - Yingwei Hu, Punit Shah, David J. Clark, Minghui Ao, Hui Zhang) / Status : Unreviewed
- Large-scale intact glycopeptide identification by Mascot database search (2018 - Ravi Chand Bollineni, Christian Jeffrey Koehler, Randi Elin Gislefoss, Jan Haug Anonsen, Bernd Thiede) / Status : Unreviewed
- Alpha-1-antitrypsin / Homo sapiens
- QLAHQSNSTNIFFSPVSIATAFAMLSLGTK (30aa)
- YLGNATAIFFLPDEGK (16aa)
- YLGNATAIFFLPDEGK (16aa)
- YIGNATAIFFIPDEGK (16aa)
- VVNPTQK (7aa)
-
- Hex:5 HexNAc:4 dHex:3 / N-Linked (avg mass : 2079.9363)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Alpha-1-antitrypsin / Homo sapiens
- NATAIFFLPDEGK (13aa)
- YIGNATAIFFIPDEGK (16aa)
-
- Hex:6 HexNAc:4 NeuAc:1 / N-Linked (avg mass : 2094.9076)
- Reanalysis of global proteomic and phosphoproteomic data identified a large number of glycopeptides (2018 - Yingwei Hu, Punit Shah, David J. Clark, Minghui Ao, Hui Zhang) / Status : Unreviewed
- Large-scale intact glycopeptide identification by Mascot database search (2018 - Ravi Chand Bollineni, Christian Jeffrey Koehler, Randi Elin Gislefoss, Jan Haug Anonsen, Bernd Thiede) / Status : Unreviewed
- Alpha-1-antitrypsin / Homo sapiens
- YLGNATAIFFLPDEGK (16aa)
- YLGNATAIFFLPDEGK (16aa)
- YIGNATAIFFIPDEGK (16aa)
-
- Hex:4 HexNAc:5 dHex:3 / N-Linked (avg mass : 2120.9889)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Alpha-1-antitrypsin / Homo sapiens
- NATAIFFLPDEGK (13aa)
-
- Hex:5 HexNAc:5 dHex:2 / N-Linked (avg mass : 2136.9883)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Alpha-1-antitrypsin / Homo sapiens
- YIGNATAIFFIPDEGK (16aa)
-
- Hex:6 HexNAc:5 dHex:1 / N-Linked (avg mass : 2152.9877)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Alpha-1-antitrypsin / Homo sapiens
- YIGNATAIFFIPDEGK (16aa)
-
- Hex:4 HexNAc:6 dHex:2 / N-Linked (avg mass : 2178.0409)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Alpha-1-antitrypsin / Homo sapiens
- YIGNATAIFFIPDEGK (16aa)
-
- Hex:4 HexNAc:6 dHex:2 / O-Linked (avg mass : 2178.0409)
- Urine (UBERON_0001088)
- Prostate cancer (DOID:10283)
- Alpha-1-antitrypsin / Homo sapiens
- YLGNATAIFFLPDEGK (16aa)
- YLGNATAIFFLPDEGK (16aa)
-
- Hex:5 HexNAc:6 dHex:1 / N-Linked (avg mass : 2194.0403)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Alpha-1-antitrypsin / Homo sapiens
- YLGNATAI (8aa)
- YIGNATAIFFIPDEGK (16aa)
-
- Hex:6 HexNAc:6 / N-Linked (avg mass : 2210.0397)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Alpha-1-antitrypsin / Homo sapiens
- YIGNATAIFFIPDEGK (16aa)
-
- Hex:5 HexNAc:4 NeuAc:2 / N-Linked (avg mass : 2224.0231)
- Blood Plasma (UBERON_0001969)
- Blood Serum (UBERON_0001977)
- Mammary Gland (UBERON_0001911)
- Urine (UBERON_0001088)
- N-Linked / Complex / NeuAc(?2-?)Gal(?1-?)GlcNAc(?1-?)Man(a1-3)[NeuAc(?2-?)Gal(?1-?)GlcNAc(?1-?)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / Complex / NeuAc(a2-6)Gal(b1-4)GlcNAc(b1-2)Man(a1-3)[NeuAc(a2-6)Gal(b1-4)GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- Site-Specific Profiling of Serum Glycoproteins Using N-Linked Glycan and Glycosite Analysis Revealing Atypical N-Glycosylation Sites on Albumin and α-1B-Glycoprotein (2018 - Shisheng Sun, Yingwei Hu, Li Jia, Shadi Toghi Eshghi, Yang Liu, Punit Shah, Hui Zhang) / Status : Unreviewed
- Reanalysis of global proteomic and phosphoproteomic data identified a large number of glycopeptides (2018 - Yingwei Hu, Punit Shah, David J. Clark, Minghui Ao, Hui Zhang) / Status : Unreviewed
- Large-scale intact glycopeptide identification by Mascot database search (2018 - Ravi Chand Bollineni, Christian Jeffrey Koehler, Randi Elin Gislefoss, Jan Haug Anonsen, Bernd Thiede) / Status : Unreviewed
- Distinct urinary glycoprotein signatures in prostate cancer patients (2018 - Rebeca Kawahara, Fabio Ortega, Livia Rosa-Fernandes, Vanessa Guimarães, Daniel Quina, Willian Nahas, Veit Schwämmle, Miguel Srougi, Katia R.M. Leite, Morten Thaysen-Andersen, Martin R. Larsen and Giuseppe Palmisano) / Status : Unreviewed
- Selective glycopeptide profiling by acetone enrichment and LC/MS (2014 - Takakura D, Harazono A, Hashii N, Kawasaki N) / Status : Reviewed
- Comparison of sialylated N-glycopeptide levels in serum of pancreatic cancer patients, acute pancreatitis patients, and healthy controls (2014 - Kontro H, Joenväärä S, Haglund C, Renkonen R) / Status : Reviewed
- Glycomic analysis of high density lipoprotein shows a highly sialylated particle (2014 - Huang J1, Lee H, Zivkovic AM, Smilowitz JT, Rivera N, German JB, Lebrilla CB) / Status : Reviewed
- Simultaneous glycosylation analysis of human serum glycoproteins by high-performance liquid chromatography/tandem mass spectrometry (2008 - Harazono A, Kawasaki N, Itoh S, Hashii N, Matsuishi-Nakajima Y, Kawanishi T, Yamaguchi T) / Status : Reviewed
- Alpha-1-antitrypsin / Homo sapiens
- QLAHQSNSTNIFFSPVSIATAF (22aa)
- QLAHQSNSTNIFFSPVSIATAFAMLSLGTK (30aa)
- QLAHQSNSTNIF (12aa)
- QLAHQSNSTNIFFSPV (16aa)
- QLAHQSNSTNIFF (13aa)
- ADTHDEILEGLNFNLTEIPEAQ (22aa)
- ADTHDEILEGLNFNLTEIPEAQIHEGFQEL (30aa)
- ADTHDEILEGLNFNLTEIPEAQIH (24aa)
- ADTHDEILEGLNFNLTEIPEAQIHEGF (27aa)
- ADTHDEILEGLNFNLTEIPEAQIHE (25aa)
- ADTHDEIIEGINFNITEIPEAQIHEGFQEIIR (32aa)
- ADTHDEILEGLNFNLTEIPEAQIHEG (26aa)
- ADTHDEILEGLNFNLT (16aa)
- NATAIFFLPDEGK (13aa)
- YIGNATAIFFIPDEGKIQHIENEITHDIITK (31aa)
- YLGNATAI (8aa)
- YIGNATAIFFIPDEGK (16aa)
- LGNATAIFFLPDEGK (15aa)
- KYLGNATAIFFLPDEGK (17aa)
- YLGNATAIFFLPDEGK (16aa)
- YLGNATAIFFLPDEGK (16aa)
- YLGNATAIF (9aa)
-
- Hex:5 HexNAc:4 dHex:2 NeuAc:1 / N-Linked (avg mass : 2225.0512)
- Reanalysis of global proteomic and phosphoproteomic data identified a large number of glycopeptides (2018 - Yingwei Hu, Punit Shah, David J. Clark, Minghui Ao, Hui Zhang) / Status : Unreviewed
- Large-scale intact glycopeptide identification by Mascot database search (2018 - Ravi Chand Bollineni, Christian Jeffrey Koehler, Randi Elin Gislefoss, Jan Haug Anonsen, Bernd Thiede) / Status : Unreviewed
- Distinct urinary glycoprotein signatures in prostate cancer patients (2018 - Rebeca Kawahara, Fabio Ortega, Livia Rosa-Fernandes, Vanessa Guimarães, Daniel Quina, Willian Nahas, Veit Schwämmle, Miguel Srougi, Katia R.M. Leite, Morten Thaysen-Andersen, Martin R. Larsen and Giuseppe Palmisano) / Status : Unreviewed
- Alpha-1-antitrypsin / Homo sapiens
- YLGNATAIFFLPDEGK (16aa)
- YLGNATAIFFLPDEGK (16aa)
- YIGNATAIFFIPDEGK (16aa)
-
- Hex:6 HexNAc:4 dHex:1 NeuAc:1 / N-Linked (avg mass : 2241.0506)
- Reanalysis of global proteomic and phosphoproteomic data identified a large number of glycopeptides (2018 - Yingwei Hu, Punit Shah, David J. Clark, Minghui Ao, Hui Zhang) / Status : Unreviewed
- Large-scale intact glycopeptide identification by Mascot database search (2018 - Ravi Chand Bollineni, Christian Jeffrey Koehler, Randi Elin Gislefoss, Jan Haug Anonsen, Bernd Thiede) / Status : Unreviewed
- Distinct urinary glycoprotein signatures in prostate cancer patients (2018 - Rebeca Kawahara, Fabio Ortega, Livia Rosa-Fernandes, Vanessa Guimarães, Daniel Quina, Willian Nahas, Veit Schwämmle, Miguel Srougi, Katia R.M. Leite, Morten Thaysen-Andersen, Martin R. Larsen and Giuseppe Palmisano) / Status : Unreviewed
- Alpha-1-antitrypsin / Homo sapiens
- ADTHDEIIEGINFNITEIPEAQIHEGFQEIIR (32aa)
- YLGNATAI (8aa)
- YLGNATAIFFLPDEGK (16aa)
- YLGNATAIFFLPDEGK (16aa)
- YIGNATAIFFIPDEGK (16aa)
-
- Hex:6 HexNAc:4 dHex:3 / N-Linked (avg mass : 2242.0787)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Alpha-1-antitrypsin / Homo sapiens
- YIGNATAIFFIPDEGK (16aa)
-
- Hex:4 HexNAc:5 dHex:2 NeuAc:1 / N-Linked (avg mass : 2266.1038)
- Reanalysis of global proteomic and phosphoproteomic data identified a large number of glycopeptides (2018 - Yingwei Hu, Punit Shah, David J. Clark, Minghui Ao, Hui Zhang) / Status : Unreviewed
- Distinct urinary glycoprotein signatures in prostate cancer patients (2018 - Rebeca Kawahara, Fabio Ortega, Livia Rosa-Fernandes, Vanessa Guimarães, Daniel Quina, Willian Nahas, Veit Schwämmle, Miguel Srougi, Katia R.M. Leite, Morten Thaysen-Andersen, Martin R. Larsen and Giuseppe Palmisano) / Status : Unreviewed
- Alpha-1-antitrypsin / Homo sapiens
- YLGNATAIFFLPDEGK (16aa)
- YLGNATAIFFLPDEGK (16aa)
- YIGNATAIFFIPDEGK (16aa)
-
- Hex:5 HexNAc:5 dHex:1 NeuAc:1 / N-Linked (avg mass : 2282.1032)
- Urine (UBERON_0001088)
- Prostate cancer (DOID:10283)
- Alpha-1-antitrypsin / Homo sapiens
- YLGNATAIFFLPDEGK (16aa)
- YLGNATAIFFLPDEGK (16aa)
-
- Hex:3 HexNAc:6 dHex:2 NeuAc:1 / N-Linked (avg mass : 2307.1564)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Alpha-1-antitrypsin / Homo sapiens
- YIGNATAIFFIPDEGK (16aa)
-
- Hex:6 HexNAc:6 dHex:1 / N-Linked (avg mass : 2356.1827)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Alpha-1-antitrypsin / Homo sapiens
- YIGNATAIFFIPDEGK (16aa)
-
- Hex:12 HexNAc:2 / N-Linked (avg mass : 2370.1141)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Alpha-1-antitrypsin / Homo sapiens
- QLAHQSNSTNIFFSPVSIATAFAMLSLGTK (30aa)
- ADTHDEIIEGINFNITEIPEAQIHEGFQEIIR (32aa)
- YLGNATAI (8aa)
- YIGNATAIFFIPDEGK (16aa)
-
- Hex:4 HexNAc:5 NeuAc:1 NeuGc:1 / N-Linked
- Urine (UBERON_0001088)
- Prostate cancer (DOID:10283)
- Alpha-1-antitrypsin / Homo sapiens
- YLGNATAIFFLPDEGK (16aa)
- YLGNATAIFFLPDEGK (16aa)
-
- Hex:5 HexNAc:4 dHex:1 NeuAc:2 / N-Linked (avg mass : 2370.1661)
- Site-Specific Profiling of Serum Glycoproteins Using N-Linked Glycan and Glycosite Analysis Revealing Atypical N-Glycosylation Sites on Albumin and α-1B-Glycoprotein (2018 - Shisheng Sun, Yingwei Hu, Li Jia, Shadi Toghi Eshghi, Yang Liu, Punit Shah, Hui Zhang) / Status : Unreviewed
- Reanalysis of global proteomic and phosphoproteomic data identified a large number of glycopeptides (2018 - Yingwei Hu, Punit Shah, David J. Clark, Minghui Ao, Hui Zhang) / Status : Unreviewed
- Large-scale intact glycopeptide identification by Mascot database search (2018 - Ravi Chand Bollineni, Christian Jeffrey Koehler, Randi Elin Gislefoss, Jan Haug Anonsen, Bernd Thiede) / Status : Unreviewed
- Distinct urinary glycoprotein signatures in prostate cancer patients (2018 - Rebeca Kawahara, Fabio Ortega, Livia Rosa-Fernandes, Vanessa Guimarães, Daniel Quina, Willian Nahas, Veit Schwämmle, Miguel Srougi, Katia R.M. Leite, Morten Thaysen-Andersen, Martin R. Larsen and Giuseppe Palmisano) / Status : Unreviewed
- Selective glycopeptide profiling by acetone enrichment and LC/MS (2014 - Takakura D, Harazono A, Hashii N, Kawasaki N) / Status : Reviewed
- Simultaneous glycosylation analysis of human serum glycoproteins by high-performance liquid chromatography/tandem mass spectrometry (2008 - Harazono A, Kawasaki N, Itoh S, Hashii N, Matsuishi-Nakajima Y, Kawanishi T, Yamaguchi T) / Status : Reviewed
- Alpha-1-antitrypsin / Homo sapiens
- ADTHDEIIEGINFNITEIPEAQIHEGFQEIIR (32aa)
- YLGNATAIFFLPDEGK (16aa)
- YLGNATAIFFLPDEGK (16aa)
- YIGNATAIFFIPDEGK (16aa)
-
- Hex:5 HexNAc:4 dHex:3 NeuAc:1 / N-Linked (avg mass : 2371.1942)
- Blood Serum (UBERON_0001977)
- Prostate cancer (DOID:10283)
- Alpha-1-antitrypsin / Homo sapiens
- YLGNATAIFFLPDEGK (16aa)
- YLGNATAIFFLPDEGK (16aa)
-
- Hex:5 HexNAc:4 dHex:1 NeuAc:1 NeuGc:1 / N-Linked (avg mass : 2386.1655)
- Urine (UBERON_0001088)
- Prostate cancer (DOID:10283)
- Alpha-1-antitrypsin / Homo sapiens
- YLGNATAIFFLPDEGK (16aa)
- YLGNATAIFFLPDEGK (16aa)
-
- Hex:6 HexNAc:4 NeuAc:2 / N-Linked (avg mass : 2386.1655)
- Blood Serum (UBERON_0001977)
- Prostate cancer (DOID:10283)
- Alpha-1-antitrypsin / Homo sapiens
- YLGNATAIFFLPDEGK (16aa)
- YLGNATAIFFLPDEGK (16aa)
-
- Hex:6 HexNAc:7 / N-Linked (avg mass : 2413.2347)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Alpha-1-antitrypsin / Homo sapiens
- NATAIFFLPDEGK (13aa)
-
- Hex:5 HexNAc:5 NeuAc:2 / N-Linked (avg mass : 2427.2181)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Alpha-1-antitrypsin / Homo sapiens
- YIGNATAIFFIPDEGK (16aa)
-
- Hex:5 HexNAc:8 / N-Linked (avg mass : 2454.2873)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Alpha-1-antitrypsin / Homo sapiens
- NATAIFFLPDEGK (13aa)
-
- Hex:3 HexNAc:9 dHex:1 / N-Linked (avg mass : 2479.3405)
- Urine (UBERON_0001088)
- Prostate cancer (DOID:10283)
- Alpha-1-antitrypsin / Homo sapiens
- YLGNATAIFFLPDEGK (16aa)
- YLGNATAIFFLPDEGK (16aa)
-
- Hex:5 HexNAc:6 dHex:3 / O-Linked (avg mass : 2486.3263)
- Urine (UBERON_0001088)
- Prostate cancer (DOID:10283)
- Alpha-1-antitrypsin / Homo sapiens
- YLGNATAIFFLPDEGK (16aa)
- YLGNATAIFFLPDEGK (16aa)
-
- Hex:6 HexNAc:4 dHex:2 NeuAc:1 / N-Linked
- Blood Serum (UBERON_0001977)
- Prostate cancer (DOID:10283)
- Alpha-1-antitrypsin / Homo sapiens
- YLGNATAIFFLPDEGK (16aa)
- YLGNATAIFFLPDEGK (16aa)
-
- Hex:7 HexNAc:4 dHex:1 / N-Linked (avg mass : 2111.9351)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Alpha-1-antitrypsin / Homo sapiens
- YIGNATAIFFIPDEGK (16aa)
-
- Hex:7 HexNAc:4 NeuAc:1 / N-Linked (avg mass : 2257.05)
- Urine (UBERON_0001088)
- Prostate cancer (DOID:10283)
- Alpha-1-antitrypsin / Homo sapiens
- YLGNATAIFFLPDEGK (16aa)
- YLGNATAIFFLPDEGK (16aa)
-
- Hex:6 HexNAc:5 NeuAc:1 / N-Linked (avg mass : 2298.1026)
- Reanalysis of global proteomic and phosphoproteomic data identified a large number of glycopeptides (2018 - Yingwei Hu, Punit Shah, David J. Clark, Minghui Ao, Hui Zhang) / Status : Unreviewed
- Large-scale intact glycopeptide identification by Mascot database search (2018 - Ravi Chand Bollineni, Christian Jeffrey Koehler, Randi Elin Gislefoss, Jan Haug Anonsen, Bernd Thiede) / Status : Unreviewed
- Alpha-1-antitrypsin / Homo sapiens
- ADTHDEIIEGINFNITEIPEAQIHEGFQEIIR (32aa)
- VVNPTQK (7aa)
-
- Hex:6 HexNAc:5 dHex:1 NeuAc:1 / N-Linked (avg mass : 2444.2456)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Alpha-1-antitrypsin / Homo sapiens
- YIGNATAIFFIPDEGK (16aa)
-
- Hex:6 HexNAc:5 NeuAc:2 / N-Linked (avg mass : 2589.3605)
- Site-Specific Profiling of Serum Glycoproteins Using N-Linked Glycan and Glycosite Analysis Revealing Atypical N-Glycosylation Sites on Albumin and α-1B-Glycoprotein (2018 - Shisheng Sun, Yingwei Hu, Li Jia, Shadi Toghi Eshghi, Yang Liu, Punit Shah, Hui Zhang) / Status : Unreviewed
- Reanalysis of global proteomic and phosphoproteomic data identified a large number of glycopeptides (2018 - Yingwei Hu, Punit Shah, David J. Clark, Minghui Ao, Hui Zhang) / Status : Unreviewed
- Large-scale intact glycopeptide identification by Mascot database search (2018 - Ravi Chand Bollineni, Christian Jeffrey Koehler, Randi Elin Gislefoss, Jan Haug Anonsen, Bernd Thiede) / Status : Unreviewed
- Alpha-1-antitrypsin / Homo sapiens
- ADTHDEIIEGINFNITEIPEAQIHEGFQEIIR (32aa)
- YLGNATAIFFLPDEGK (16aa)
- YLGNATAIFFLPDEGK (16aa)
- YIGNATAIFFIPDEGK (16aa)
-
- Hex:6 HexNAc:5 dHex:2 NeuAc:1 / N-Linked (avg mass : 2590.3886)
- Blood Serum (UBERON_0001977)
- Prostate cancer (DOID:10283)
- Alpha-1-antitrypsin / Homo sapiens
- YLGNATAIFFLPDEGK (16aa)
- YLGNATAIFFLPDEGK (16aa)
-
- Hex:6 HexNAc:5 dHex:1 NeuAc:2 / N-Linked (avg mass : 2735.5035)
- Reanalysis of global proteomic and phosphoproteomic data identified a large number of glycopeptides (2018 - Yingwei Hu, Punit Shah, David J. Clark, Minghui Ao, Hui Zhang) / Status : Unreviewed
- Large-scale intact glycopeptide identification by Mascot database search (2018 - Ravi Chand Bollineni, Christian Jeffrey Koehler, Randi Elin Gislefoss, Jan Haug Anonsen, Bernd Thiede) / Status : Unreviewed
- Alpha-1-antitrypsin / Homo sapiens
- ADTHDEIIEGINFNITEIPEAQIHEGFQEIIR (32aa)
- YLGNATAIFFLPDEGK (16aa)
- YLGNATAIFFLPDEGK (16aa)
-
- Hex:6 HexNAc:6 NeuAc:2 / N-Linked (avg mass : 2792.5555)
- Blood Serum (UBERON_0001977)
- Prostate cancer (DOID:10283)
- Alpha-1-antitrypsin / Homo sapiens
- VVNPTQK (7aa)
-
- Hex:6 HexNAc:5 NeuAc:3 / N-Linked (avg mass : 2880.6184)
- N-Linked / Complex / NeuAc(a2-3)Gal(b1-4)GlcNAc(b1-4)[NeuAc(a2-6)Gal(b1-4)GlcNAc(b1-2)]Man(a1-?)[NeuAc(a2-6)Gal(b1-4)GlcNAc(b1-2)Man(a1-?)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- Site-Specific Profiling of Serum Glycoproteins Using N-Linked Glycan and Glycosite Analysis Revealing Atypical N-Glycosylation Sites on Albumin and α-1B-Glycoprotein (2018 - Shisheng Sun, Yingwei Hu, Li Jia, Shadi Toghi Eshghi, Yang Liu, Punit Shah, Hui Zhang) / Status : Unreviewed
- Reanalysis of global proteomic and phosphoproteomic data identified a large number of glycopeptides (2018 - Yingwei Hu, Punit Shah, David J. Clark, Minghui Ao, Hui Zhang) / Status : Unreviewed
- Large-scale intact glycopeptide identification by Mascot database search (2018 - Ravi Chand Bollineni, Christian Jeffrey Koehler, Randi Elin Gislefoss, Jan Haug Anonsen, Bernd Thiede) / Status : Unreviewed
- Selective glycopeptide profiling by acetone enrichment and LC/MS (2014 - Takakura D, Harazono A, Hashii N, Kawasaki N) / Status : Reviewed
- Alpha-1-antitrypsin / Homo sapiens
- ADTHDEIIEGINFNITEIPEAQIHEGFQEIIR (32aa)
- YLGNATAIFFLPDEGK (16aa)
- YLGNATAIFFLPDEGK (16aa)
- YIGNATAIFFIPDEGK (16aa)
-
- Hex:6 HexNAc:5 dHex:2 NeuAc:2 / N-Linked (avg mass : 2881.6465)
- Blood Serum (UBERON_0001977)
- Prostate cancer (DOID:10283)
- Alpha-1-antitrypsin / Homo sapiens
- YLGNATAIFFLPDEGK (16aa)
- YLGNATAIFFLPDEGK (16aa)
-
- Hex:7 HexNAc:5 dHex:1 NeuAc:2 / N-Linked (avg mass : 2897.6459)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Alpha-1-antitrypsin / Homo sapiens
- ADTHDEIIEGINFNITEIPEAQIHEGFQEIIR (32aa)
- YIGNATAIFFIPDEGK (16aa)
-
- Hex:6 HexNAc:6 dHex:1 NeuAc:2 / N-Linked (avg mass : 2938.6985)
- Blood Serum (UBERON_0001977)
- Prostate cancer (DOID:10283)
- Alpha-1-antitrypsin / Homo sapiens
- VVNPTQK (7aa)
-
- Hex:7 HexNAc:6 NeuAc:2 / N-Linked (avg mass : 2954.6979)
- Blood Serum (UBERON_0001977)
- Prostate cancer (DOID:10283)
- Alpha-1-antitrypsin / Homo sapiens
- VVNPTQK (7aa)
-
- Hex:6 HexNAc:5 dHex:1 NeuAc:3 / N-Linked (avg mass : 3026.7614)
- Site-Specific Profiling of Serum Glycoproteins Using N-Linked Glycan and Glycosite Analysis Revealing Atypical N-Glycosylation Sites on Albumin and α-1B-Glycoprotein (2018 - Shisheng Sun, Yingwei Hu, Li Jia, Shadi Toghi Eshghi, Yang Liu, Punit Shah, Hui Zhang) / Status : Unreviewed
- Reanalysis of global proteomic and phosphoproteomic data identified a large number of glycopeptides (2018 - Yingwei Hu, Punit Shah, David J. Clark, Minghui Ao, Hui Zhang) / Status : Unreviewed
- Large-scale intact glycopeptide identification by Mascot database search (2018 - Ravi Chand Bollineni, Christian Jeffrey Koehler, Randi Elin Gislefoss, Jan Haug Anonsen, Bernd Thiede) / Status : Unreviewed
- Selective glycopeptide profiling by acetone enrichment and LC/MS (2014 - Takakura D, Harazono A, Hashii N, Kawasaki N) / Status : Reviewed
- Alpha-1-antitrypsin / Homo sapiens
- QLAHQSNSTNIFFSPVSIATAFAMLSLGTK (30aa)
- ADTHDEIIEGINFNITEIPEAQIHEGFQEIIR (32aa)
- YLGNATAIFFLPDEGK (16aa)
- YLGNATAIFFLPDEGK (16aa)
- YIGNATAIFFIPDEGK (16aa)
-
- Hex:7 HexNAc:6 dHex:1 NeuAc:2 / N-Linked (avg mass : 3100.8409)
- Blood Serum (UBERON_0001977)
- Prostate cancer (DOID:10283)
- Alpha-1-antitrypsin / Homo sapiens
- VVNPTQK (7aa)
-
- Hex:7 HexNAc:6 dHex:1 NeuAc:4 / N-Linked (avg mass : 3683.3567)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Alpha-1-antitrypsin / Homo sapiens
- ADTHDEIIEGINFNITEIPEAQIHEGFQEIIR (32aa)
-
- Hex:7 HexNAc:6 dHex:3 NeuAc:1 / N-Linked
- Blood Serum (UBERON_0001977)
- Prostate cancer (DOID:10283)
- Alpha-1-antitrypsin / Homo sapiens
- YLGNATAIFFLPDEGK (16aa)
- YLGNATAIFFLPDEGK (16aa)
-
- Hex:8 HexNAc:3 dHex:3 NeuAc:1 / N-Linked
- Blood Serum (UBERON_0001977)
- Prostate cancer (DOID:10283)
- Alpha-1-antitrypsin / Homo sapiens
- YLGNATAIFFLPDEGK (16aa)
- YLGNATAIFFLPDEGK (16aa)
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Suggested structure
Reference
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Suggested structure
Reference
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Suggested structure
Reference
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Suggested structure
Reference
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Suggested structure
Reference
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Suggested structure
Reference
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Suggested structure
Reference
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Suggested structure
Reference
Reported glycosite
Mass spectrometry observed peptide
Suggested structure
Reference
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Reference
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Suggested structure
Reference
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Suggested structure
Reference
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Suggested structure
Reference
Reported glycosite
Mass spectrometry observed peptide
Suggested structure
Reference
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Suggested structure
Reference
Reported glycosite
Mass spectrometry observed peptide
Suggested structure
Disease
Reference
Reported glycosite
Mass spectrometry observed peptide
Suggested structure
Reference
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Disease
Reported glycosite
Suggested glycosite
Source
Disease
Reported glycosite
Suggested glycosite
Source
Disease
Reported glycosite
Suggested glycosite
Disease
Reported glycosite
Suggested glycosite
Disease
Reported glycosite
Suggested glycosite
Source
Disease
Reported glycosite
Suggested glycosite
Source
Disease
Reported glycosite
Suggested glycosite
Source
Disease
Reported glycosite
Suggested glycosite
Disease
Reported glycosite
Suggested glycosite
Disease
Reported glycosite
Suggested glycosite
